Drug Targets the Underlying Cause of the Disease in People with the Most Common CF Mutation
CF Foundation Provided Scientific, Clinical and Significant Funding Support in Drug Development Process
|
5 min read
Kalydeco Marks the Latest Success of the Cystic Fibrosis Foundation’s Venture Philanthropy Model
|
5 min read
New Effort Will Search for Potential Therapies Targeting the Most Common Mutation of Cystic Fibrosis
|
4 min read